Skip to content Skip to footer

Market News

HomeAll PostsMarket News
A volatile tape has produced an unexpectedly investable combination: major retailers are receiving fresh tariff refunds, mortgage rates have edged lower, and the debate around California’s proposed wealth tax underscores rather than erases Silicon Valley’s enduring economic gravity. For investors, the message…
U.S. stocks finished broadly higher on Wednesday, August 19, as a pullback in long-dated Treasury yields improved risk appetite, a pause in proposed Canadian tariffs reduced a near-term trade overhang, and a landmark oncology update sparked an extraordinary biotech rally. The S&P…
U.S. stocks closed lower Tuesday, August 18, 2026, with technology shares and small-cap stocks sustaining the sharpest losses. The selling followed renewed pressure from elevated oil prices, historically high long-dated Treasury yields, and economic data showing a sizable decline in U.S. housing…
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has delivered the kind of Phase 3 result biotechnology investors wait patiently—and, on occasion, not so patiently—for. The company reported that avexitide reduced the composite rate of severe and clinically meaningful post-bariatric hypoglycemia events by 55% versus…
U.S. stocks moved lower in afternoon trading and into the close on Monday as investors weighed rising geopolitical and energy-market risks against ongoing enthusiasm for artificial intelligence infrastructure. The selling was broad-based, with the Dow Jones Industrial Average, S&P 500, Nasdaq Composite,…
Load more posts